Xiaobing Zhang
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 2
-
- Extracellular vesicles in disease 5
- Metabolomics and Mass Spectrometry Studies 2
- Advanced biosensing and bioanalysis techniques 2
-
- Peptidase Inhibition and Analysis 3
-
- Nanoplatforms for cancer theranostics 3
Xiaobing Zhang
19 papers receiving 368 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 119
- Molecular Biology 270
- Oncology 73
- Cell Biology 29
- Immunology and Allergy 9
Countries citing papers authored by Xiaobing Zhang
This map shows the geographic impact of Xiaobing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Zhang more than expected).
Fields of papers citing papers by Xiaobing Zhang
This network shows the impact of papers produced by Xiaobing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Zhang. The network helps show where Xiaobing Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaobing Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 41 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 33 | |
| 8 | 2023 | 47 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 24 | |
| 11 | 2019 | 106 | |
| 12 | 2019 | 1 | |
| 13 | 2018 | 6 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 37 | |
| 16 | 2015 | 1 | |
| 17 | 2015 | 39 | |
| 18 | 2009 | 1 | |
| 19 | 2009 | 13 |
About Xiaobing Zhang
Xiaobing Zhang is a scholar working on Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 19 papers that have together received 372 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (4 papers), Peptidase Inhibition and Analysis (3 papers), Nanoplatforms for cancer theranostics (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (119 citations), Molecular Biology (270 citations) and Oncology (73 citations). Xiaobing Zhang has collaborated with scholars based in China, Netherlands and Australia. Frequent co-authors include Jufeng Guo, Jian Liu, Rui Tao, Sylvia E. Le Dévédec, Huib Ovaa, Alfred C.O. Vertegaal, Roman I. Koning, Maarten van Dinther, Prasanna Vasudevan Iyengar and Long Zhang. Their work appears in journals such as Angewandte Chemie International Edition, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.